RecruitingNot applicableNCT05610566

Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China

Studying Anorectal malformation

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peijia Medical Technology (Suzhou) Co., Ltd.
Intervention
the HighLife Trans-Septal Transcatheter Mitral Valve Replacement System(device)
Enrollment
110 target
Eligibility
18 years · All sexes
Timeline
2022 – 2029

Study locations (1)

Collaborators

West China Hospital · Second Affiliated Hospital, School of Medicine, Zhejiang University · The Second Affiliated Hospital of Harbin Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05610566 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation →

← Back to all trials